News

Media enquiries

Topics related to gender identity - and issues that are relevant to many trans people's lives - have thankfully been receiving greater attention in the UK in recent years. This includes increasing interest in our service and what we do.

We welcome media enquiries about our work. Please contact our Trust’s dedicated press office who will be happy to help.

Permission granted to appeal High Court judgment on consent for puberty-blocking treatment

On 1 December 2020 the High Court ruled that children and young people may not be able to consent to puberty-blocking treatment in cases of gender dysphoria.

The Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS), has today (Monday 18 January) been granted permission by the court to appeal against the ruling, alongside University College Hospitals NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, whose paediatric endocrinologists prescribe and administer puberty-blocking drugs on behalf of GIDS. 

On 1 December 2020 the High Court ruled that children and young people may not be able to consent to puberty-blocking treatment in cases of gender dysphoria.

The Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS), has today (Monday 18 January) been granted permission by the court to appeal against the ruling, alongside University College Hospitals NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, whose paediatric endocrinologists prescribe and administer puberty-blocking drugs on behalf of GIDS. 

Our statement in response to the court’s decision today is as follows:

A spokesperson for the Trust said: “We welcome the court’s decision to allow us to appeal against the ruling. Our priority is to work together with our partners to support our patients and their families while legal proceedings are ongoing.”

For accurate and up-to-date information about the ruling and the appeal visit the GIDS website: https://gids.nhs.uk.

Journalists should email communications@tavi-port.nhs.uk 

Update on GIDS Judicial Review and timetable for clinical reviews, 22 December 2020

The Tavistock and Portman NHS Foundation Trust, together with University College London Hospitals NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, has today sought permission to appeal the order of the Divisional Court handed down on 1 December in the case brought against us, Bell v Tavistock

In the meantime, we continue to work with partners and our commissioner NHS England to respond to the requirements of the judgment.

Our first and foremost consideration is the wellbeing of our patients and their families. We have been working with partners to design a robust clinical review process for assessing cases of patients currently undergoing endocrine treatment and those currently awaiting treatment.  These Clinical Reviews will provide the basis for making best interest applications to the Courts in cases where it is recommended that treatment should continue. Although we will also be undertaking clinical reviews of 16- and 17-year olds, a best interest application will only be needed where there is any doubt about their best interests.

In finalising this process we will be working with Royal Colleges and other experts. The process of clinical review will begin at the end of January.  Further detail about the court process which would follow individual clinical reviews will be set out in the New Year.

Finally, we would like to again assure existing patients that their care will not be discontinued unless a patient and their clinician decides to withdraw from puberty blockers or if a court decides it is not in an individual’s best interests.  At present we have paused new referrals to endocrinology.  We will keep this decision under review as we progress with the case reviews and court applications for existing patients.

Read a Q&A for patients and clinicians on the GIDS website.

Update on the Judicial Review, Tuesday 1 December 2020

The Trust is disappointed by today’s judgment and we understand that the outcome is likely to cause anxiety for patients and their families. Our first duty is to our patients, particularly those currently receiving hormone blocking treatment and we are working with our partners, University College London Hospitals NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, to provide support for patients concerned about the impact on their care.

The Trust is seeking permission to appeal the judgment, and in the meantime, confirms its ongoing support for the review commissioned by NHS England being led by Dr Hilary Cass.

We will update our statement once we know the outcome of today’s further court proceedings.

3.30pm update:

The Court has ruled that there will be a stay on implementation of its judgment until the later of 22 December or the determination of any appeal. This will give us a chance to work through the specific implications of the judgment for different patient groups with our partners, University College London Hospitals NHS Foundation Trust and Leeds Teaching Hospitals Trust. We will not be making new referrals to endocrinology until we have more clarity.


If you are a young person or family and have questions about what this might mean for you, please head to our page with answers to commons questions.